Design, Synthesis and Evaluation of Antibacterial Effects of a New Class of Piperazinylquinolone Derivatives

Pentafluoropyridine derivatives and cyanuric chloride were used for the synthesis of new piperazinylquinolone derivatives. These reactions provided N-fluoropyridiyl and N-cyanoryl chloride piperazinylquinolone derivatives in good yields. Synthesized compounds were evaluated for their antibacterial activities. These compounds displayed good to excellent antibacterial activities.

[1]  A. Katritzky,et al.  Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates. , 2014, Bioorganic & medicinal chemistry letters.

[2]  K. Parang,et al.  Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines. , 2013, Bioorganic & medicinal chemistry letters.

[3]  S. Assar,et al.  Synthesis of N-aryl-2,2,2-trifluoroacetimidoyl piperazinylquinolone derivatives and their antibacterial evaluations , 2011 .

[4]  Xingshu Li,et al.  4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents. , 2010, Bioorganic & medicinal chemistry letters.

[5]  R. Kiss,et al.  7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents. , 2009, Bioorganic & medicinal chemistry.

[6]  G. Thomas,et al.  Synthesis of citrate-ciprofloxacin conjugates. , 2009, Bioorganic & medicinal chemistry letters.

[7]  Susan Deeter,et al.  Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[8]  J. Howard,et al.  Synthesis of tetrahydropyrido[2,3- b ]pyrazine scaffolds from 2,3,5,6-tetrafluoropyridine derivatives , 2007 .

[9]  A. Shafiee,et al.  Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen-2-yl]-2-(oxyimino)ethyl]piperazinylquinolone derivatives. , 2006, Bioorganic & medicinal chemistry.

[10]  A. Kranjc,et al.  Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa. , 2005, Current pharmaceutical design.

[11]  J. Howard,et al.  Polyfunctional tetrahydropyrido[2,3-b]pyrazine scaffolds from 4-phenylsulfonyl tetrafluoropyridine. , 2005, The Journal of organic chemistry.

[12]  L. D. Luca,et al.  [1,3,5]-Triazine: A Versatile Heterocycle in Current Applications of Organic Chemistry , 2004 .

[13]  J. Gage,et al.  Novel oxazolidinone-quinolone hybrid antimicrobials. , 2003, Bioorganic & medicinal chemistry letters.

[14]  D. Hoppensteadt,et al.  Factor Xa inhibitors: today and beyond. , 2003, Current opinion in investigational drugs.

[15]  A. Sartorelli,et al.  SYNTHESIS OF HALOGEN-SUBSTITUTED 3-DEAZAADENOSINE AND 3-DEAZAGUANOSINE ANALOGUES AS POTENTIAL ANTITUMOR/ANTIVIRAL AGENTS , 2001, Nucleosides, nucleotides & nucleic acids.

[16]  J. Verhoef,et al.  Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. , 1999, International journal of antimicrobial agents.

[17]  G. Brooke.  The preparation and properties of polyfluoro aromatic and heteroaromatic compounds , 1997 .

[18]  T. Seay,et al.  Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. , 1996, The Journal of urology.

[19]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.